Capital Wealth Planning, LLC Bristol Myers Squibb CO Transaction History

Capital Wealth Planning, LLC

$9.25 Billion
Q1 2024

A detailed history of Capital Wealth Planning, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Wealth Planning, LLC holds 14,440 shares of BMY stock, worth $584,098. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,440

Previous 14,940 3.35%

Holding current value

$584,098

Previous $766,000 2.22%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $23,990 - $27,200	-500 Reduced 3.35%	14,440 $783,000
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $260,773 - $311,175	-5,379 Reduced 26.47%	14,940 $766,000
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $190,052 - $212,508	3,283 Added 19.27%	20,319 $1.18 Million
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $22,808 - $25,324	358 Added 2.15%	17,036 $1.09 Million
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $657,099 - $745,300	-10,000 Reduced 37.48%	16,678 $1.16 Million

Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $69 - $41,339	538 Added 2.06%	26,678 $1.9 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $220,619 - $242,979	-3,038 Reduced 10.41%	26,140 $2.01 Million
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $614,800 - $737,200	-10,000 Reduced 25.52%	29,178 $2.13 Million
Q4 2021 Feb 04, 2022	SELL	$53.63 - $62.52 $96,909 - $112,973	-1,807 Reduced 4.41%	39,178 $2.44 Million
Q3 2021 Nov 03, 2021	SELL	$59.17 - $69.31 $260,288 - $304,894	-4,399 Reduced 9.69%	40,985 $2.43 Million
Q2 2021 Aug 03, 2021	SELL	$61.91 - $67.42 $18,573 - $20,226	-300 Reduced 0.66%	45,384 $3.03 Million
Q1 2021 Apr 19, 2021	SELL	$59.34 - $66.74 $49,192 - $55,327	-829 Reduced 1.78%	45,684 $2.88 Million
Q4 2020 Jan 25, 2021	SELL	$57.74 - $65.43 $462,612 - $524,225	-8,012 Reduced 14.69%	46,513 $3 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $128,758 - $142,680	-2,242 Reduced 3.95%	54,525 $3.29 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $1.93 Million - $2.26 Million	35,239 Added 163.69%	56,767 $3.34 Million
Q1 2020 Apr 30, 2020	SELL	$46.4 - $67.43 $37,120 - $53,944	-800 Reduced 3.58%	21,528 $1.2 Million
Q4 2019 Feb 26, 2020	BUY	$49.21 - $64.19 $47,733 - $62,264	970 Added 4.54%	22,328 $1.43 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $357,215 - $423,529	-8,352 Reduced 28.11%	21,358 $1.16 Million
Q2 2019 Aug 02, 2019	BUY	$44.62 - $49.34 $922,072 - $1.02 Million	20,665 Added 228.47%	29,710 $1.35 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $221,614 - $287,380	4,545 Added 101.0%	9,045 $470,000
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $250,838 - $282,926	-4,545 Reduced 50.25%	4,500 $0
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $541,976 - $623,924	9,045 New	9,045 $0
Q3 2017 Nov 15, 2017	SELL	$55.23 - $63.74 $384,842 - $444,140	-6,968 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	6,968	6,968 $388,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Wealth Planning, LLC with notifications on news.

Account

Capital Wealth Planning, LLC Bristol Myers Squibb CO Transaction History